Analyst Reco. Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Market Closed - Nyse Other stock markets 04:00:02 2024-05-17 pm EDT			Pre-market 08:46:19 am
0.8056 ^USD	-3.98%		0.815	+1.17%

May. 16	Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing	MT
May. 15	BTIG Downgrades Ginkgo Bioworks Holdings to Sell From Neutral, Price Target is $0.50	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ginkgo Bioworks Holdings Insider Bought Shares Worth $514,750, According to a Recent SEC Filing	May. 16	MT
BTIG Downgrades Ginkgo Bioworks Holdings to Sell From Neutral, Price Target is $0.50	May. 15	MT
Morgan Stanley Trims Ginkgo Bioworks Price Target to $1 From $2, Maintains Equal Weight Rating	May. 15	MT
Ginkgo Bioworks Holdings Insider Bought Shares Worth $271,815, According to a Recent SEC Filing	May. 14	MT
Ginkgo Bioworks Holdings Insider Sold Shares Worth $1,606,162, According to a Recent SEC Filing	May. 14	MT
William Blair Downgrades Ginkgo Bioworks Holdings to Underperform From Market Perform	May. 10	MT
TD Cowen Cuts Price Target on Ginkgo Bioworks to $3 From $7, Maintains Outperform Rating	Mar. 01	MT
Goldman Sachs Trims Ginkgo Bioworks Price Target to $1.10 From $1.25, Maintains Sell Rating	Jan. 22	MT
Raymond James Downgrades Ginkgo Bioworks to Market Perform From Outperform, Price Target is $2.50	Nov. 14	MT
BTIG Downgrades Ginkgo Bioworks Holdings to Neutral From Buy	Nov. 09	MT
Goldman Sachs Downgrades Ginkgo Bioworks to Sell From Neutral, Adjusts Price Target to $1.25 From $3	23-06-02	MT
William Blair Downgrades Ginkgo Bioworks Holdings to Market Perform From Outperform	23-05-11	MT
Berenberg Bank Initiates Coverage on Ginkgo Bioworks With Buy Rating, $4 Price Target	22-11-29	MT
Morgan Stanley Starts Ginkgo Bioworks Holdings at Equalweight With $5 Price Target	22-10-04	MT
BTIG Adjusts Price Target on Ginkgo Bioworks Holdings to $6 From $5, Reiterates Buy Rating	22-08-16	MT
Raymond James Adjusts Price Target on Ginkgo Bioworks Holdings to $14.50 From $11.50, Keeps Outperform Rating	22-08-16	MT
Jefferies Adjusts Price Target on Ginkgo Bioworks Holdings to $4.35 From $11.50, Reiterates Buy Rating	22-06-16	MT
BofA Securities Downgrades Ginkgo Bioworks Holdings to Underperform From Neutral, Adjusts Price Target to $3 From $6	22-05-18	MT
Cowen Initiates Ginkgo Bioworks Holdings at Outperform With $12 Price Target	22-03-02	MT
Goldman Sachs Starts Ginkgo Bioworks Holdings at Neutral With $7 Price Target	22-02-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Ginkgo Bioworks Holdings, Inc.

Equities

DNA

US37611X1000

Analyst Reco.

Filters